07:00 , Jul 26, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Basic helix-loop-helix family member e41 (BHLHE41; BHLHB3; DEC2) Patient sample and mouse studies suggest BHLHE41 could help treat and diagnose triple-negative breast cancer....
07:00 , Apr 9, 2009 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Cancer Breast cancer Basic helix-loop-helix family, member e41 (BHLHE41; SHARP-1); cyclin G2 (CCNG2) In vitro studies and clinical specimen analysis suggest...